相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer
A. Tutt et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial
J. O'Shaughnessy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer
Kenji Shibuta et al.
BREAST CANCER (2011)
Triple-negative breast cancer-current status and future directions
O. Gluz et al.
ANNALS OF ONCOLOGY (2009)
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Carey K. Anders et al.
CLINICAL BREAST CANCER (2009)
Triple negative breast cancers: Clinical and prognostic implications
S.J. Dawson et al.
EUROPEAN JOURNAL OF CANCER (2009)
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
Bhumsuk Keam et al.
BMC CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
分享论文
